Results 221 to 230 of about 577,818 (354)

Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma: Morphological appraisal with a comprehensive review of differential diagnoses

, 2020
MukulK Divatia, Ziad M. El‐Zaatari
openalex   +1 more source

Engineered CAR‐NKT Extracellular Vesicles Suppress Tumor Progression and Enhance Antitumor Immunity

Advanced Science, EarlyView.
TM4SF1‐nanobody engineered CAR‐natural killer T–derived extracellular vesicles (CARTM4SF1‐EVs) provide a cell‐free alternative to CAR‐NKT therapy, achieving potent, targeted antitumor activity with reduced toxicity. CARTM4SF1‐EVs induce immunogenic cell death, remodel the tumor microenvironment, and enhance CD8⁺ T‐cell antitumor immunity.
Xiaopei Hao, Chengming Qu, Yanzhao Zhou, Xiaoqian Wang, Xiangjun Qian, Xun Chen, Feng Han, Xiaokai Zhang, Yiyi Ji, Han Li, ChengWei Ju, Peng Xia, Weiwei Tang, Hao Zhuang, Jinxue Zhou   +14 more
wiley   +1 more source

Renal Cell Carcinoma with Fibromyomatous Stroma: A Case Report. [PDF]

Am J Case Rep
Keshk EM, Kashif A, Alsulaiman AS, Abdullah NA, Alafghani SO, Alzahrani HSJ, Alghamdi EM, Alhuthali RK, Alasiri KA, Alharthi RF, Alharthi RF, Barnawi HR, Alotaibi WM.   +12 more
europepmc   +1 more source

MP85-12 DIOSMETIN ENHANCES TRAIL-INDUCED APOPTOSIS IN RENAL CARCINOMA CELLS THROUGH THE UP-REGULATION OF DEATH RECEPTOR 5 [PDF]

, 2016
Yu Ren, Xuping Yao, Xue Wang, Shuaishuai Huang, Guobin Weng   +4 more
openalex   +1 more source

Engineering Immune Cell to Counteract Aging and Aging‐Associated Diseases

Advanced Science, EarlyView.
This review highlights a paradigm shift in which advanced immune cell therapies, initially developed for cancer, are now being harnessed to combat aging. By engineering immune cells to selectively clear senescent cells and remodel pro‐inflammatory tissue microenvironments, these strategies offer a novel and powerful approach to delay age‐related ...
Jianhua Guo, Lanjie Lei, Ying Jin, Lan Su, Shumao Cui, Liyun Shi   +5 more
wiley   +1 more source

Non‑coding RNAs in epithelial‑mesenchymal transition of renal cell carcinoma (Review). [PDF]

Mol Med Rep
Liu Z, Zhou H, Shen J, Qi Y, Gong X, Zhang C.   +5 more
europepmc   +1 more source

Single‐Cell Morphomechanics of Prostate Cancer‐Associated Fibroblasts Identifies Distinct Features Associated with Patient Outcome

Advanced Science, EarlyView.
Cancer‐associated fibroblasts (CAFs) in prostate tumors exhibit distinct morphomechanical traits vs normal fibroblasts, including greater stiffness and volume, more elongated stress fibres, and larger and more elongated nuclei. These features, quantified through imaging and real‐time deformability cytometry, correlate with patient outcomes and can be ...
Antje Garside, Angela Jacobi, Shivakumar Keerthikumar, Vaibhav Mahajan, Michelle Richards, Birunthi Niranjan, Linda Teng, Nicholas Choo, Johannes Low Jun Wei, Gail P Risbridger, Mitchell G Lawrence, Anna V. Taubenberger   +11 more
wiley   +1 more source

Preliminary exploration of the putative function of SF3A2 in clear cell renal cell carcinoma. [PDF]

Mol Med Rep
Chen R, Xu J.
europepmc   +1 more source

Late metastasis from clear cell renal carcinoma to testicles [PDF]

, 2017
Patrícia Zuková, Jan Pokorný, Romana Badejová   +2 more
openalex   +1 more source

CXC Chemokine‐Driven Vascular Reprogramming: Modulating Tumor Vasculature to Boost Therapeutic Response

Advanced Science, EarlyView.
Tumor vascular remodeling is discussed from a chemokine‐centered perspective. This review summarizes the bidirectional, temporal, and tissue‐specific roles of CXC chemokines in regulating vascular function and immune accessibility. A functional vascular normalization score is introduced as a conceptual framework to integrate dynamic vascular and immune
Hongdan Chen, Yinde Huang, Juntong Wu, Ziying Yi, Yao Li, Zeyu Yang, Fan Zhang, Chong Li   +7 more
wiley   +1 more source